Home > Indonesia
Indonesia Bans Cough Syrup Material Linked To Gambia Child Deaths
Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (AFP/Milan Breckmans)
October 17th, 2022 | 16:31 PM | 474 views
JAKARTA
Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.
The Food and Drug Monitoring Agency (BPOM) also said it was investigating the possibility that the ingredients, diethylene glycol and ethylene glycol, had contaminated other materials that are used as solvents.
Gambia and India are investigating the deaths from acute kidney injury in the west-African country thought to be linked to cough syrups made by New Delhi-based Maiden Pharmaceuticals Ltd.
The World Health Organization has said it found "unacceptable" levels of the ingredients, which can be toxic, in four Maiden products.
"To provide protection to the public, BPOM has set a requirement at the time of registration that all medicinal syrup products for children and adults are not allowed to use diethylene glycol (DEG) and ethylene glycol (EG)," the regulator said in a statement.
The BPOM reiterated that the four products linked to the deaths in Gambia are not registered in Indonesia, nor any other Maiden products.
Source:
courtesy of THE JAKARTA POST
by Reuters
If you have any stories or news that you would like to share with the global online community, please feel free to share it with us by contacting us directly at [email protected]